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Abstract: Background: Indoor air pollution is still considered one of the leading causes of morbidity
and mortality worldwide. We aimed to investigate the potential association between indoor
particulate matter (PM) and fasting clinic blood pressure in adult Australians. Methods: Sixty-three
participants residing within the Perth metropolitan area were studied. Participants were aged between
18 and 65 years and free of major medical conditions. We conducted 24-h monitoring of residential PM
concentrations, including the size fractions PM1, PM2.5, PM4, and PM10. All participants attended a
clinical assessment at Curtin University following a 10–12 h overnight fast. Results: In this study we
found that PM1 and PM2.5 were significantly associated with heart rate: a one interquartile range
(IQR) increase in PM1 or PM2.5 was associated with a 4–6 beats per minute (bpm) increase in heart
rate. Both PM10 and total PM exposure had a significant impact on systolic blood pressure (SBP):
a one IQR increase in PM10 and total PM were associated with a 10 mmHg (95% CI: 0.77–20.05) and
12 mmHg (2.28–22.43 mmHg) increase in SBP, respectively. Conclusion: The study findings provide
additional support to the thesis that indoor air pollution is an important modifiable factor in the risk
of hypertension.
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1. Introduction
Despite decades of progress in both the prevention and the management of individuals with
elevated blood pressure (BP), suboptimal BP remains the single, most important contributor to the
global burden of cardiovascular diseases [1,2]. In recent years, there has been a growing appreciation of
the role of poor air quality in health outcomes, especially in relation to respiratory and cardiovascular
diseases (CVD). In 2014, the World Health Organization identified air pollution as the largest single
environmental health risk factor, responsible for an estimated 3.7 million deaths in 2012 [3].
Particulate air pollution is a complex mixture of all the solid and liquid particles suspended
in air and can include both organic and inorganic particles, such as dust, pollen, soot, and smoke.
The particulate matter (PM) in air is typically classified by size into coarse (PM10; <10 µm mean
aerodynamic diameter), fine (PM2.5; <2.5 µm diameter), and ultrafine (UFP; <0.1 µm diameter) fractions.
The main source of indoor particles is from outdoor air, however indoor activities such as cooking
or indoor combustion [4]; smoking [5]; vaping [6]; secondary formation processes [7] and dust
resuspension are also considered as significant contributors to indoor aerosols. Ambient aerosols
in urban environments usually originate predominantly from fossil fuel burning, car emissions,
resuspension, and chemical and thermodynamic processes, but can also come from long range
transport [8]. Due to their diverse sources, airborne particles span a large size range, from a few
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nanometers to tens of micrometers in diameter. However, most studies to date have identified PM2.5 as
having the strongest adverse effects on health, particularly vascular outcomes [9–11]. The mechanisms
underlying the relationship between exposure to particulate matter and markers of vascular health
remain unclear but increased oxidative stress and inflammation have been reported as possible
pathways mediating the relationship [10,12,13]. In addition, recent research has demonstrated that PM
also affects the cardiovascular system directly by entry into the systemic circulation [14]. This process
causes myocardial dysfunction through reactive oxygen species production, calcium ion interference,
and vascular dysfunction.
Traditionally, epidemiological studies have focused on the associations between outdoor air
pollution and cardiovascular (CV) health outcomes. However, there is increasing evidence that poor
indoor air quality (IAQ) may also be associated with adverse vascular and respiratory outcomes. It has
been estimated that in high-income countries, individuals spend up to 90% of their time indoors,
of which nearly two-thirds is spent in their primary residence; thus, indoor air quality may be a
potential risk factor for human health [15,16]. According to Morawska et al. [17], between 10–30% of
the global burden of disease from PM exposure is attributable to indoor-generated particles. However,
most of the studies to date have been conducted in lower- and middle-income countries where levels
of air quality—both indoors and outdoors—are significantly poorer that in high-income countries.
According to the World Bank, high-income economies are those with a per capita gross national
income (GNI) of $12,056 or more, which includes Australia [18]. To date, few studies have examined
the relationship between indoor-generated particulate matter and markers of vascular health in a
high-income setting. The objective of this study was to investigate the potential association between
different indoor PM size fractions and both BP and heart rate (HR) outcomes in adult Australians.
2. Methods
The study included volunteers (n = 63) residing within the Perth metropolitan area, aged between
18 and 65 years, who were free of major medical conditions including type 2 diabetes, cardiovascular
disease and cancer. We applied the convenience sampling method, with study subjects recruited via
advertising through radio and pamphlets distributed at the Curtin University campus. The Human
Research Ethics Committee at Curtin University provided approval for the study.
2.1. Measurement of Indoor Air Quality
In this study we examined the potential association between chronic exposures, not acute
exposures, to air pollutants and a chronic condition of altered resting BP. In a similar air quality
study, 24-h measurement was considered sufficient time to capture long term domestic exposure to
air pollutants [19,20]. This sampling duration was applied in the current study. Real-time measurements
of PM concentrations were conducted using a TSI DustTrak™ Aerosol Monitor Model 8530 (TSI Inc.,
Shoreview, MN, USA)), with a size-selective inlet conditioner. The monitor operated at a flow rate of
1.7 L/min. Monitoring was conducted over a 24-h period in participants’ living room at breathing height
and concentrations of particles with different sizes including PM10, PM4, PM2.5 and PM1 were recorded.
In addition to the regular annual factory calibration, the DustTrak™ was custom calibrated using
the integral 37 mm filter at some selected site locations, to determine the gravimetric concentration.
The custom calibration factor was reused at all measurement sites. A TinyTag Ultra 2TM data logger
(Gemini Data Loggers (UK) Ltd., Chichester, West Sussex, UK) was used to measure indoor temperature
and relative humidity. All measurements were conducted during weekdays and participants were
asked to maintain their usual behavioral patterns.
2.2. Measurement of Covariates
A modified structured questionnaire, based on the questionnaire of the American Thoracic Society
for respiratory symptoms [21], and applied in other studies [22–24], was used to elicit the required data.
The questionnaire comprised two parts: (a) individual data on the participant’s age, education, gender, and
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some general questions about health, physical activities and diet, and (b) data on the participant’s home
environment, including exposure to cigarette smoke and type of heating and cooling present in the home.
2.3. Assessment of Heart Rate and Blood Pressure
All participants were invited to come to Curtin University for clinical assessment. Following a
10–12 h overnight fast, minimum 8 h sleep and abstinence from alcohol and from nicotine (for those
who smoked), participants arrived at the clinical suite in the School of Public Health where body
weight and composition was determined using a bio-impedance analysis (BIA) instrument (Inbody
3.0, InBodyCo. Ltd., Seoul, Korea). Following a mandatory 30 min rest in bed, with an appropriate
sized BP cuff in place on exposed arm, BP and HR (Omron, Kyoto, Japan), were measured in triplicate
and the lowest two readings were averaged. All measurements followed a standard protocol, used
in previous studies [25,26]. The order of measurements was random, with participants either having
their clinical parameters measured first, followed by the indoor air pollution of their homes, or vice
versa. The interval between these measures was at most 3 weeks.
2.4. Statistical Analysis
In this study, the main outcome variables were HR and systolic (SBP) and diastolic (DBP) blood
pressure (mmHg). The exposure variables of interest were indoor measurements of PM1, PM2.5,
PM4, and PM10. Descriptive statistics were produced to describe the profile and characteristics of
participants and to summarize the outcome variables and the exposure/independent variables of
interest. All outcome variables were assessed for normality and the natural logarithm transformation
was applied to HR. The natural logarithm transformed HR was used in the multiple regression analysis.
The estimated coefficients, which correspond to the expected geometric mean of the HR measurements,
were then back transformed using the exponential function to calculate relevant changes in HR.
Untransformed SBP and DBP were used in all regression modellings. The geometric mean changes in
HR and the mean changes in BP corresponding to a one interquartile range (IQR) increase in indoor PM
concentrations are reported, along with their 95% confidence interval (CI) (corresponding percentage
(%) changes are reported in the supplementary figures). Multivariable linear regression analysis was
conducted to assess the association between particulate air pollution and both BP and HR, controlling
for age, gender, smoking (in house), body mass index (BMI), high BP status (yes vs. no prior to
recruitment), use of prescription medicines (yes vs. no) and McAuley’s Insulin Sensitivity Index (ISI;
an index based on insulin and triglyceride levels) for all subjects. Subgroup analyses used the same
list of covariates, with high BP status and smoking removed accordingly.
In this study a negative confounding effect on the association between PM concentration and the
outcome variables (in particular HR) was observed. To identify the variable/s with the potential to
cause this effect, multivariable linear regression analysis was conducted multiple times with a different
variable or combination of variables removed in each model. The above modelling procedures and
the assessments of negative confounding were repeated separately for a subgroup comprised of the
non-hypertensive subjects (n = 41). All statistical analyses were performed using SPSS version 22 (IBM,
Armonk, NY, USA).
3. Results
A total of 63 subjects (55% women) with a mean age of 61 years (SD = 9) were recruited into
the study. Almost half of the participants (49%, n = 31) reported taking blood-pressure-lowering
medication. The mean SBP and DBP values were 130.3 mmHg (SD = 17.7 mmHg) and 75.1 mmHg
(SD = 10.0 mmHg), respectively. Mean HR was 63.3 beats per minute (bpm; SD = 12.6 bpm). Additional
baseline characteristics for study participants are shown in Table 1. The occupants of 38 (60.3%)
households were exposed to mean PM2.5 concentrations that were within the WHO Guideline
(≤25 µg/m3), whereas 20 households (32%) had a mean PM2.5 that exceeded the guideline value and
five houses showed no detectable PM2.5. Summary data on the levels of indoor particulate matter,
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temperature and relative humidity are presented in Table 2. Four participants (6%) reported current
smoking of cigarettes in the house. In these households the median PM10 and total PM levels were
significantly (p = 0.002) higher compared with the smoke-free households: 89 µg/m3 and 153 µg/m3
versus 29 µg/m3 and 62 µg/m3, respectively. In addition, total PM levels were significantly higher
(p < 0.05) in households located less than 300 m from a major road than in those situated away from a
main thoroughfare: 67 µg/m3 versus 48 µg/m3, respectively.
Table 1. Summary of participants by indoor PM2.5 concentration (based on all subjects n = 63).
Variables Overall (n = 63) Missing Cases n (%)
PM2.5 * (µg/m3)
<25 ≥25 p § Value
Age (years) 61 (9.00) 0 (0) 61 (9.30) 63 (9.50) 0.306
BMI (kg/m2) 28.71 ± 5.64 6 (9.52) 28.36 ± 6.29 29.28 ± 4.51 0.569
Born in Australia
Yes 34 (54.00) 0 (0) 20 (66.70) 10 (33.30) 0.849
No 29 (46.00) 18 (64.30) 10 (35.70)
Smokers in house
Yes 4 (6.30) 0 (0) 3 (75.00) 1 (25.00) 1.000
No 59 (93.7) 35 (64.80) 19 (35.20)
Drinker
Yes 8 (12.70) 0 (0) 6 (85.70) 1 (14.30) 0.403
No 55 (87.30) 32 (62.70) 19 (37.30)
Diabetes
Yes 20 (31.70) 0 (0) 9 (50.00) 9 (50.00) 0.095
No 43 (68.30) 29 (72.50) 11 (27.50)
Hypertensive
Yes 20 (32.70) 2 (3.17) 13 (68.40) 6 (31.60) 0.790
No 41 (65.10) 24 (64.90) 13 (35.10)
Prescription medicine
Yes 31 (49.2) 0 (0) 19 (65.50) 10 (34.50)
No 32 (50.8) 19 (65.50) 10 (34.50) 1.000
HR (bpm) 63.25 (12.63) 11 (17.46) 62.5 (12.38) 65 (13.50) 0.214
SBP (mmHg) 130.25 ± 17.69 11 (17.46) 128.00 ±16.51
133.85 ±
19.32 0.250
DBP (mmHg) 75.12 ± 9.98 11 (17.46) 73.88 ±10.20 77.10 ± 9.52 0.261
McAuley’s ISI 8.40 ± 2.65 15 (23.81) 8.27 ± 2.67 8.59 ± 2.69 0.694
Continuous variables (age, BMI, HR, SBP, DBP and McAuley’s ISI) are presented as mean ± standard deviation (SD)
if symmetrical or as median (IQR) if skewed. Categorical variables (born in Australia, smoking, drinker, diabetes,
hypertensive, prescription medicine) are presented as n (%). § p-value correspond to an independent samples t-test
(symmetrical continuous data), or a Mann-Whitney U test (skewed continuous data), or either a chi-square test
or Fishers’ exact test if applicable (categorical data). * Categorized based on WHO guidelines (2005). BMI: body
mass index; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; ISI: McAuley’s Insulin
Sensitivity Index.
Table 2. Summary statistics for indoor PM concentration, temperature and relative humidity (n = 63).
Variable * Mean SD Median IQR Min Max
PM1 (µg/m3) 17.62 20.23 6.00 32.00 0.00 62.00
PM2.5 (µg/m3) 18.74 19.92 7.00 31.00 1.00 62.00
PM4 (µg/m3) 21.91 21.83 8.00 31.50 2.00 71.00
PM10 (µg/m3) 37.29 22.49 34.50 38.00 10.00 95.00
PMTotal (µg/m3) 66.16 30.50 63.00 32.25 23.00 168.00
Temperature (◦C) 23.09 3.54 23.42 5.09 16.52 32.16
Relative humidity (%) 53.24 13.13 54.84 15.87 0.64 84.70
* Five (7.94%) households had missing values for all variables. IQR: interquartile range.
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Association between Levels of Indoor Particulate Matter with Heart Rate and Blood Pressure
In the crude-model adjusted only for age and gender, there was a positive trend observed in HR
with increasing exposure to each PM size fraction: an increase in one IQR for each of the exposure
measures was associated with an approximate increase in HR of 3–4 bpm. In the analysis adjusted
for age, gender, smoking, BMI, high BP, use of prescription medicines and McAuley’s ISI, there was
a significant association of PM1 and PM2.5 with HR such that a one IQR increase in exposure was
associated with an approximately 4 bpm increase in HR (Table 3).
Table 3. Unit changes (95% CI) in outcome variables associated with a one interquartile range (IQR)
increase in indoor PM concentration exposures—for all subjects (n = 63).
Outcome
Variable
n
Indoor Air Quality (µg/m3)
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 31.5) PM10 (IQR = 38) Total PM (IQR = 32.25)
HR (bpm)
CModel 52 2.93 (−0.89, 6.99) 3.04 (−0.72, 7.02) 3.80 * (0.34, 7.45) 4.47 * (0.37, 8.83) 3.00 * (0.49, 5.61)
AModel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8.71) 3.13 (−1.31, 7.88) 3.39 (−2.44, 9.78) 0.91 (−3.46, 5.60)
SBP (mmHg)
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) 1.77 (−4.89, 8.44) 3.38 (−4.43, 11.18) 2.94 (−1.90, 7.78)
AModel 45 1.63 (−6.26, 9.53) 1.75 (−6.05, 9.55) −0.31 (−8.74, 8.11) 3.86 (−7.11, 14.83) 5.89 (−2.25, 14.04)
DBP (mmHg)
CModel 52 0.32 (−3.78, 4.43) 0.45 (−3.59, 4.49) 1.83 (−1.88, 5.55) 2.24 (−2.13, 6.62) 2.01 (−0.69, 4.71)
AModel 45 2.04 (−2.11, 6.18) 2.03 (−2.07, 6.13) 1.96 (−2.46, 6.38) 2.70 (−3.10, 8.50) 1.57 (−2.85, 5.98)
Crude model: adjusted for age and gender. Adjusted model: adjusted for age, gender, BMI, smokers in house,
hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural logarithmic transformation
was used. The estimated coefficients corresponding to the expected geometric mean of the HR were then back
transformed using an exponential function * p < 0.05.
When the analysis was restricted to those who were not diagnosed as hypertensives nor reported
taking blood-pressure-lowering medication (n = 41), the relationship was strengthened, as a one IQR
increase in PM1 and PM2.5 was associated with a 6 bpm higher HR (Table 4). Excluding the current
smokers from the analysis (n = 4) did not significantly affect the results.
Table 4. Unit changes (95% CI) in outcome variables associated with one IQR increase in indoor PM
concentration exposures—for non-hypertensive subjects (n = 41).
Outcome
Variable
n
Indoor Air Quality (µg/m3)
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) Total PM (IQR = 32.25)
HR (beat/minute)
CModel 33 5.43 * (0.05, 11.26) 5.67 * (0.35, 11.44) 6.03 * (1.09, 11.35) 6.05 * (1.11, 11.37) 4.96
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(1.66, 8.43)
AModel 30 6.15 * (1.32, 11.34) 6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84)
SBP (mmHg)
CModel 33 4.55 (−3.64, 12.73) 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.56) 7.16
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DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.1 , 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.8 , 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: adjusted for age and gender. Adjusted model: adjusted for age, gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated coefficients corresponding to the expected 
geometric mean of the HR were then back transformed using an exponential function.  p < 0.01, * p < 
0.05,  p < 0.1. 
There were weak positive associations between levels of indoor particulate matter and both SBP 
and DBP in the adjusted model but none were statistically significant (Table 3). When the data was 
analyzed for only those who were not diagnosed as hypertensives nor taking blood-pressure-
lowering medication (n = 43), the associations were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(−0.19, 14.51) 6.97
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Association between Levels of Indoor Particulate Matter with Heart Rate and Blood Pressure 
In the crude- odel adjusted only for age and gender, there was a positive trend observe  in HR 
with increasing exposure to each PM size fraction: an increase in one IQR for each of the exposure 
measures was associated with an approximate increase in HR of 3–4 bpm. In the analysis adjusted 
for age, gender, smoking, BMI, high BP, use of prescription medicines and McAuley’s ISI, there was 
a significant association of PM1 and PM2.5 with HR such that a one IQR increase in exposure was 
assoc ated with an approximately 4 bpm increase in HR (Table 3). 
Table 3. Unit changes (95% CI) in outcome variables associated with a one interquartile range (IQR) 
increase in indoor PM concentration exposures—for all subjects (n = 63).  
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 1.5) PM10 (IQR = 38) Total PM (IQR = 32.25) 
HR (bpm)  
CModel 52 2.93 (−0.89, 6.99) .04 (−0.72, 7.02) 3.80 * 0.34, 7.45) 4.47 * (0 37 8.83) 3.00 * (0 49 5.61) 
AModel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8 7 ) 3.13 (−1.31, 7.88) 3.39 (−2.44, 9.78) 0.91 (−3.46, 5.60) 
SBP (mmHg)  
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) 1.77 (−4.89, 8 4 ) 3.38 (−4.43, 11 18 2.94 (−1.90, 7.78) 
AModel 45 .63 (−6.26, 9.53) 1.75 (−6.05, 9.55) −0.31 (−8.74, 8.11) 3.86 (−7.11, 14.83) 5.89 (−2.25, 14.04) 
DBP (mmHg)  
CModel 52 0.32 (−3.78, 4.43) 0.45 (−3.59, 4.49) 1.83 (−1.88, 5.55) 2.24 (−2.13, 6.62) 2.01 (−0.69, 4.71) 
AModel 45 2.04 (−2.11, 6.18) 2.03 (−2.07, 6.13) 1.96 (−2.46, 6.38) 2.70 (−3.10, 8.50) 1.57 (−2.85, 5.98) 
Crude odel: djus ed for ag  and gender. Adjusted model: adjusted for age, gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
logarithmic tr nsformation was used. The estimated coefficients corresponding to th  expect d 
geometric m an of the HR were the  back tra sformed using an exponential function * p < 0.05. 
When the analysis was restricted to those who were not diagnosed as hypertensives nor reported 
taking blood-pressure-lowering medication (n = 41), the relationship was strengthened, as a one IQR 
increase in PM1 and PM2.5 was associa ed with a 6 bpm h gher HR (Table 4). Excluding the current 
smokers from the analysis (n = 4) did not sign ficantly affect the results.  
Table 4. Unit changes (95% CI) in outcome variables associated with one IQR increase in indoor PM 
concentration exposures—for non-hypertensive subjects (n = 41). 
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) 
Total PM (IQR = 
32.25) 
HR (beat/minute)  
CModel 33 5.4  * (0.05, 11.26) 5.67 * (0.35, 11.44) 6.03 * (1.09, 1 .35) 6.05 * ( .11, 11.37) 4.96  (1.66, 8.43) 
AModel 0 6.15 * (1.32, 11.3 ) 6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84) 
SBP (mmHg)  
CModel 33 4.5  (−3.64, 12 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.5 ) 7.16  (−0.19, 14.51) 6.97  (2.16, 11.79) 
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) .65 (−6.06, 13.37) 10.01  (−0.61, 20.63) 13.44  (4.07, 22.81) 
DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.13, 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.84, 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: djus ed for age and gender. Adjusted model: adjusted for age, gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated coefficients corresponding to the expected 
geom tric mean of the HR were then back transformed using an exp nential f nc ion.  p < 0.01, * p < 
0.05,  p < 0.1. 
There were weak positive associations bet een levels of indoor particulate matter and both SBP 
and DBP in the adjusted model but none were statistically significant (Table 3). When the data was 
analyzed for only those who were not diagnosed as hypertensives nor taking blood-pressure-
lowering medication (n = 43), the associations were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(2.16, 11.79)
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) 3.65 (−6.06, 13.37) 10.01
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Association between Levels of Indoor Particulate Matter with Heart Rate and Blood Pressure 
I  the crude-m del adjusted only for age and ge der, there was a positive trend observed in HR 
with increasing exposure to each PM size fraction: an increase in one IQR for each of the exposure 
measures was associated with an approximate increase i  HR of 3–4 bpm. In the analysis adjusted 
for age, gender, smoki g, BMI, high BP, use of prescription medicines and McAuley’s ISI, there as 
a significant association of PM1 and PM2.5 with HR such that a one IQR increase in exposure was 
associated with an approximately 4 bpm increase in HR (Table 3). 
Table 3. Unit changes (95% CI) in outcome variables associated with a one interquartile range (IQR) 
increase in indoor PM concentration exposures—for all subjects (n = 63).  
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 31.5) PM10 (IQR = 8) Total PM (IQR = 32.25) 
HR (bpm)  
CModel 52 2.93 (−0.89, 6.99) 3.04 (−0.72, 7.02) 3.80 * (0.34, 7.45) 4.47 * (0.37, 8.83) 3.00 * (0.49, 5.61) 
AModel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8.71) 3.13 (−1.31, 7.88) 3.39 (−2.44, 9.78) 0.91 (−3.46, 5.60) 
SBP (mmHg)  
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) 1.77 (−4.89, 8.44) 3.38 (−4.43, 11.18) 2.94 (−1.90, 7.78) 
AModel 45 1.63 (−6.26, 9.53) 1.75 (−6.05, 9.55) −0.31 (−8.74, 8.11) 3.86 (−7.11, 14.83) 5.89 (−2.25, 14.04) 
DBP (mmHg)  
CModel 52 0.32 (−3.78, 4.43) 0.45 (−3.59, 4.49) 1.83 (−1.88, 5.55) 2.24 (−2.13, 6.62) 2.01 (−0.69, 4.71) 
AModel 45 2.04 (−2.11, 6.18) 2.03 (−2.07, 6.13) 1.96 (−2.46, 6.38) 2.70 (−3.10, 8.50) 1.57 (−2.85, 5.98) 
Crude model: adju ted for age and gender. Adjuste  model: djusted f  ag , gender, BMI, smoker  
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated coefficients corresponding to the expected 
geometric me n of the HR were then back transformed using an exponential function * p < 0.05. 
When the analysis was restricted to those who were not diagnosed as hypertensives nor reported 
taking blood-pressure-lowering medication (n = 41), the relationship was strengthened, as a one IQR 
i crease in PM1 and PM2.5 was associated with a 6 bpm higher HR (Table 4). Excluding the current 
smokers from the analysis (n = 4) did not significantly affect the results.  
Table 4. Unit changes (95% CI) in outcome variables a sociated with one IQR increase in indoor PM 
concentration exposures—for non-hypertensive subjects (n = 41). 
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) 
Total PM (IQR = 
32.25) 
HR (beat/minute)  
CModel 33 5.43 * (0.05, 11.26) 5.67 * (0.35, 11.44) 6.03 * (1.09, 11.35) 6.05 * (1.11, 11.37) 4.96  (1.66, 8.43) 
AModel 30 6.15 * (1.32, 11.34) 6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84) 
SBP (mmHg)  
CModel 33 4.55 (−3.64, 12.73) 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.56) 7.16  (−0.19, 14.51) 6.97  (2.16, 11.79) 
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) 3.65 (−6.06, 13.37) 10.01  (−0.61, 20.63) 13.44  (4.07, 22.81) 
DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.13, 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.84, 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: adju ted for age and gender. Adjuste  model: adjusted f  ag , gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated coefficients corresponding to the expected 
geometric mean of the HR were then back transformed using an exponential function.  p < 0.01, * p < 
0.05,  p < 0.1. 
There were weak positive associations between levels of i door particulate matter and both SBP 
and DBP in the adjusted model but none were statisticall  significant (Table 3). When the data was 
analyzed for only those who were not diagnosed as hypertensives n r taki g blood-pressure-
lowering medication (n = 43), the associatio s were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(−0.61, 20.63) 13.44
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Association between Levels of Indoor Particulate Matter with Heart Rate and Blood Pressure 
I  the crude-m del adjusted only for age and ge der, there was a positive trend observe  in HR 
with increasing exposure to each PM size fraction: an increase in o e IQR for ach of the exposure 
measures w s associated with an approximate increase i HR of 3–4 bpm. In the analysis adjusted 
for age, gender, smoki g, BMI, high BP, use of prescription medicines and McAuley’s ISI, there as 
a significant association of PM1 and PM2.5 with HR such that a o e IQR increase in exposure was 
associated with an approximately 4 bpm increase in HR (Table 3). 
Table . Unit changes (95% CI) in outcome variables associated with a one interquartile range (IQR) 
increase in indoor PM concentration exposures—for all subjects (n = 63).  
Outcome Variable n 
Indoor Ai  Quality (µg/m3) 
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 1.5) PM10 (IQR = 38) Total PM (IQR = 32.25) 
HR (bpm)  
CModel 52 2.93 (−0.89, 6.99) .04 (−0.72, 7.02) 3.80 * (0.34, 7.45) 4.47 * (0.37, 8.83) 3.00 * (0.49, 5.61) 
A odel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8 7 ) 3.13 (−1.31, 7.88) 3.39 (−2.44, 9.78) 0.91 (−3.46, 5.60) 
SBP (mmHg)  
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) 1.77 (−4.89, 8 4 ) 3.38 (−4.43, 11.18) 2.94 (−1.90, 7.78) 
AModel 45 .63 (−6.26, 9.53) 1.75 (−6.05, 9.55) −0.31 (−8.74, 8.11) 3.86 (−7.11, 14.83) 5.89 (−2.25, 14.04) 
DBP (mmHg)  
CModel 52 0.32 (−3.78, 4.43) 0.45 (−3.59, 4.49) 1.83 (−1.88, 5.55) 2.24 (−2.13, 6.62) 2.01 (−0.69, 4.71) 
AModel 45 2.04 (−2.11, 6.18) 2.03 (−2.07, 6.13) 1.96 (−2.46, 6.38) 2.70 (−3.10, 8.50) 1.57 (−2.85, 5.98) 
Crude model: adju ted for age and gender. A j ste  model: adjusted f  ag , gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For t e HR variable, natural 
logarithmic transformation was used. The estimated coefficie ts correspondin  to the expected 
geometric mean of the HR were then back transformed using an exponential function * p < 0.05. 
When the analysis was restricted to those who were not diagnosed as hypertensives or reported 
taking blood-pressure-lowering medication (n = 41), the relationship was strengthened, as a one IQR 
increase i  PM1 and PM2.5 was associated with a 6 bpm higher HR (Table 4). Excluding the current 
smokers from the analysis (n = 4) did not significantly affect the results.  
Table 4. Unit changes (95% CI) in outcome variables a sociated with one IQR increase in indoor PM 
concentration exposures—for non-hypertensive subjects (n = 41). 
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) 
Total PM (IQR = 
32.25) 
HR (beat/minute)  
CModel 33 5.43 * (0.05, 11.26) 5.67 * (0.35, 11.44) 6.03 * (1.09, 11.35) 6.05 * ( .11, 11.37) 4.96  (1.66, 8.43) 
A odel 0 6.15 * (1.32, 11.3 ) 6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84) 
SBP (mmHg)  
Model 33 4.55 (−3.64, 12.73) 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.5 ) 7.16  (−0.19, 14.51) 6.97  (2.16, 11.79) 
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) .65 (−6.06, 13.37) 10.01  (−0.61, 20.63) 13.44  (4.07, 22.81) 
DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.13, 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.84, 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: adju ted for age and gender. A j ste  model: adjusted f  ag , gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
loga ithmic transformation was used. The estimated coefficients corresponding to he expected 
geometric mean of the HR were the  back transformed using an exponential function.  p < 0.01, * p < 
0.05,  p < 0.1. 
There were weak positive associations between levels of i door particulate matter and both SBP 
and DBP in the adjusted model but none were statisticall  significant (Table 3). When th data was 
analyzed for only those who were not diagnosed as hypertensives n r taki g blood-pressure-
lowering medication (n = 43), the associatio s were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(4.07, 22.81)
DBP (mmHg)
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13
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Association between Levels of Indoor Particulate Matter with Heart Rate and Blood Pressure 
In the crude-model adj sted only for age and g nder, there was a po itiv  tr n  observ d in HR 
with increasing exposure to eac  PM size fraction: an i crease in one IQR for each of the xposure 
measures was associated with an appr xim te incr ase in HR of 3–4 bpm. In th  nalysis adjusted 
for age, gender, smoking, BMI, hi h BP, use of prescription medicines and McAuley’s ISI, there was 
a significant association of PM1 a d PM2.5 with HR such that a one IQR increas  in exposure was 
associated with an approxim tely 4 bpm increase in HR (Table 3). 
Table 3. Unit changes (95% CI) in outco e variables associated with a ne interquartile rang  (IQR)
increase in indoor PM concentration exposures—for all subjects (n = 63).  
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 31 5) P 10 (I  = 38) Total PM (IQR = 32.25) 
HR (bpm)  
CModel 52 2.93 (−0.89, 6.99) 3.04 (−0.72, 7.02) 3.80 * (0.34, 7.45) 4.47 * (0.37, 8.83) 3.00 * (0.49, 5.61) 
AModel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8.71) 3.1  (−1.31, 7.88) 3 39 2 44 9 78 0.9  (−3.46, 5.60) 
SBP (mmHg)  
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) .77 (−4.89, 8.44) 3.38 ( 4.43, 11.18) 2.94 (−1.90, 7.78) 
AModel 45 1.63 (−6.26, 9.53) 1.75 (−6.05, 9.55) −0.31 (−8.74, 8.11) 3.86 (−7.11, 14.83) 5.89 (−2.25, 14.04) 
DBP (mmHg)  
CModel 52 0.32 (−3.78, 4.43) 0.45 (−3.59, 4.49) 1.83 (−1.88, 5.55) 2.24 (−2.13, 6.62) 2.01 (−0.69, 4.71) 
AModel 45 2.04 (−2.11, 6.18) 2.03 (−2.07, 6.13) 1.96 (−2.46, 6.38) 2.70 (−3.10, 8.50) 1.57 (−2.85, 5.98) 
Crude model: adjusted for age and g nder. Adjusted model: a justed for age, gender, BMI, smokers 
in house, hypertensive, prescription m dicin , a d McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated c efficients corresponding to the exp cted 
geometric mean of he HR were then back transfo med using n exponential function * p < 0.05. 
When the analysi  was rest icted to t ose who wer  not di gnosed  h pert nsives nor rep rted 
taking blood-pressure-lowering medication (n = 41), the relati n hip was strengthened,  a one IQR 
increase in PM1 and PM2.5 was associated with a 6 bpm higher HR (Table 4). Excluding the curre t 
smokers from the analysis (n = 4) did ot significantly affect the re ults.  
Table 4. Unit changes (95% CI) in outcome variables associated with one IQR increase in indoor PM 
concentration exposures—for non-hypertensiv  subjects (n = 41). 
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) 
Total PM (IQR = 
32 25
HR (beat/minute)  
CModel 33 5.43 * (0.05, 11.26) 5.67 * (0.35, 11.44) 6. 3 * (1.09, 11.35) 6.05 * (1.11, 11.37) 4.96  (1.66, 8.43) 
AModel 30 6.15 * (1.32, 11.34  6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84) 
SBP (m g)  
CModel 33 4.55 (−3.64, 12.73) 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.56) 7.16  (−0. 9, 14.5 ) 6.97  (2.16, 11.79) 
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) 3.65 (−6.06, 13.37) 10.01  (−0.61, 20.63) 13.44  (4.07, 22.81) 
DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.13, 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.84, 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: adjusted for age and g nder. Adjusted model: a jus ed for age, gender, BMI, smokers
in house, hypertensive, prescription m dicin , a d McAuley’s ISI. For the HR variable, natural 
logarithmic transformation was used. The estimated c efficients corresponding to the exp cted 
geometric mean of the HR were then back transformed using an exponential function.  p < 0.01, * p < 
0.05,  p < 0.1. 
There were weak positiv  associations between levels f indoor pa ticul te matt r and both SBP 
and DBP in the adjusted model but none were statistically sign fica t (Table 3). When the ata was 
analyzed for only those who wer  not diagn s d as yp rt nsives nor taking bl od-pr ssur -
lowering medication (n = 43), the associations were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(−0. 3, 8.38) 4. * (0.50, 8.85) 3 69 * (0.84, 6.54)
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32
Int. J. Environ. Res. Public Health 2018, 15, x 5 of 10 
 
Association betwe  L vels of Indoor Particulate Matter with Heart Rate and Blood Pressure 
In the crude- del adjusted only for age and gender, ther  was a positive trend observed in HR 
with increasing exposure to each PM size frac ion: an increase in one IQR for ch of the exposure 
measures was associated with an approximate increase in HR of 3–4 bpm. In the analysis adjusted 
for age, g nder, smoking, BMI, hig  BP, us  of prescription medicines and McAuley’s ISI, there was 
a signific nt association of PM1 nd PM2.5 with HR such that a one IQR increase in exposure was 
associated with an pproximately 4 bpm increase in HR (Table 3). 
Table 3. U it changes (95% CI) in outcome variables associated with a one interquartile range (IQR) 
increase in indoor PM concentration exposures—for all subjects (n = 63).  
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 32) PM2.5 (IQR = 31) PM4 (IQR = 31.5) PM10 (IQR = 38) Total PM (IQR = 32.25) 
HR (bpm)  
CModel 52 2.93 (−0.89, 6.99) 3.04 (−0.72, 7.02) 3. 0 * (0.34, 7.45) 4.47 * (0.37, 8.83) 3.00 * (0.49, 5.61) 
AModel 45 4.56 * (0.45, 8.93) 4.38 * (0.31, 8.71) 3.13 (−1.31, 7.88) 3.39 (−2.44, 9.78) 0.91 (−3.46, 5.60) 
SBP (mmHg)  
CModel 52 1.43 (−5.87, 8.73) 1.65 (−5.53, 8.82) 1.77 (−4.89, 8.44) 3.38 (−4.43, 11.18) 2.94 (−1.90, 7.78) 
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Table 4. Unit changes (95% CI) in outcome variables associated with one IQR increase in indoor PM 
concentration exposures—for non-hypertensive subjects (n = 41). 
Outcome Variable n 
Indoor Air Quality (µg/m3) 
PM1 (IQR = 30.50) PM2.5 (IQR = 30) PM4 (IQR = 31) PM10 (IQR = 33) 
Total PM (IQR = 
32.25) 
HR (beat/minute)  
CModel 33 5.4  * (0.05, 1.26) 5.67 * (0.35, 11.44) 6.03 * (1.09, 1 .35) 6.05 * (1.11, 11.37) 4.96  (1.66, 8.43) 
AModel 30 6.15 * (1.32, 11.34) 6.03 * (1.18, 11.24) 4.55 (−0.87, 10.43) 4.33 (−1.50, 11.81) 4.17 (−1.90, 10.84) 
SBP (mmHg)  
Mo l 33 4.5  (−3.64, 1 . ) 4.80 (−3.31, 12.91) 3.90 (−3.78, 11.56) 7.16  (−0.19, 14.51) 6.97  (2.16, 11.79) 
AModel 30 6.32 (−2.44, 15.08) 6.40 (−2.34, 15.15) 3.65 (−6.06, 13.37) 10.01  (−0.61, 20.63) 13.44  (4.07, 22.81) 
DBP (mmHg)  
CModel 33 2.92 (−1.79, 7.64) 3.15 (−1.58, 7.85) 4.13  (−0.1 , 8.38) 4.67 * (0.50, 8.85) 3.69 * (0.8 , 6.54) 
AModel 30 3.58 (−1.58, 8.73) 3.61 (−1.55, 8.76) 3.64 (−1.93, 9.21) 5.32  (−1.01, 11.64) 4.64 (−1.48, 10.76) 
Crude model: djus ed for age and g nder. Adjusted model: adjusted for age, gender, BMI, smokers 
in house, hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural 
loga ithmic tr nsformation was used. The estimated coeffic ents corresponding to he expected 
geom tric mean of the HR were the  back transformed using an exp nential f nction.  p < 0.01, * p <
0.05,  p < 0.1. 
There were weak positive associatio s bet en levels of indoor particulate matter and both SBP 
and DBP in the adjusted odel but none were s tistically signific nt (Table 3). When the data was 
analyzed for only those who were not diagnosed as hypertensives nor taking blood-pressure-
lowering medication (  = 43), the associations were much stronger. The most pronounced effect was 
observed for total PM, a one IQR increase in total PM was associated with a 13 mmHg increase in 
SBP ((95% CI: 4.07–22.81 mmHg) (Table 4)).  
(−1.01, 11.64) 4.64 (−1.48, 10.76)
Crude model: adjusted for age and gender. Adjusted model: adjusted for age, gender, BMI, smokers in house,
hypertensive, prescription medicine, and McAuley’s ISI. For the HR variable, natural logarithmic transformation
was used. The estimated coefficients corresponding to the expected geometric mean of the HR were then back
transformed usi g an exponential function.
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p < 0.1.
There were weak positiv associations bet n levels of indoor particulate matter and both SBP
and DBP in th adjusted m el but none re s atistically significant (Table 3). When the data was
analyzed for only those who were not diagnose a hypertensives no taking lood-pressu -lowering
medication (n = 43), he ass ciations ere much stro g . T e most pronounced effect was observed
fo t tal PM, a one IQR incr ase in total P as as ociat d with a 13 m Hg ncrease in SBP ((95% CI:
4.07–22.81 mmHg) (Table 4)).
In addition, Supplementary Figures S1 and S2 show the percent change in each of the outcome
variables associated with exposure to a one IQR increase in PM concentration, for the adjusted model.
The data for the analysis of all participants is shown in Supplementary Figure S1, the data for the
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analysis of only participants that did not report a diagnosis of high BP is shown in Supplementary
Figure S2, based on these figures, each IQR increase exposure in PM1 and PM2.5 was significantly
associated with an approximate 7–8% elevation in HR on average, which was a finding consistent
across subgroups.
4. Discussion
The adverse effects of outdoor air pollution on CVD outcomes have been widely studied.
In comparison, there is a paucity of information regarding the effect of indoor air quality on CVD
health, particularly in high-income settings. In this adult study population, 24-h measures of exposure
to indoor PM, and in particular PM1 and PM2.5, were strongly associated with vascular risk markers,
which is in agreement with previous findings [12,27–29]. We found that PM1 and PM2.5 were positively
associated with HR: a one IQR increase in PM1 or PM2.5 was associated with a 4–6 bpm increase in HR.
Brook [10] and colleagues have also postulated that particulate air pollutants can trigger elevation in
HR. Similar results were reported by Zhao and colleagues [30], who established a significant association
between PM and increased HR among the Chinese population. Large-scale epidemiological studies
have demonstrated a positive relationship between HR and vascular risk. In the HARVEST study [31],
patients whose HR was persistently high during the study period of six years had a doubled risk of
developing hypertension. Fox and colleagues [32] showed that a resting HR of >70 bpm was associated
with increased cardiovascular mortality as well as an increase in hospitalization due to heart failure or
myocardial infarction.
The effects of PM on BP were somewhat equivocal but supported the existence of a positive
relationship between exposure to particular air pollution and higher SBP and DBP. Dianat and
colleagues [33] concluded that PM10 had harmful effects on the heart and on BP in healthy rats, likely
due to increased oxidative stress. In another recent study, Zhang and colleagues [34] demonstrated
that a 10 µg/m3 increase in PM2.5 concentration was associated with a 0.5 mmHg increase in SBP.
In the current study, a one IQR increase in PM10, was associated with a 10 mmHg higher SBP among
non-hypertensive participants who did not take BP medications, which is consistent with the findings
of a study conducted in Detroit [35]. Total PM appeared to also be a significant contributor to elevated
levels of SBP, as a one IQR increase in total PM was associated with a 13 mmHg (95% CI: 2.28–22.43)
higher SBP. These results clearly demonstrate that there is a wide range in the magnitude of BP
elevation between subjects and therefore susceptible individuals may respond with larger degrees of
BP elevation than the population mean.
Recent research has shown that PM can raise BP, and this effect may even persist chronically when
individuals reside in more polluted regions [36,37]. This is consistent with the findings of Brook and
colleagues [38] who provided evidence that long term PM exposure can promote the development
of hypertension. This suggests that not only can short-term PM exposures potentially cause an
acute increase in BP, but chronically inhaling second-hand smoke can increase the risk for chronic
hypertension. In a more recent study in China, Lin and colleagues [39] demonstrated that an IQR
increase of PM2.5 (19.1 µg/m3) was associated with the increase of 1.90 mmHg in SBP and 0.68 mmHg
in DBP. It should be noted that, not all studies have positive results [40,41]. The discrepancies
between previous studies may result from PM exposure mischaracterizations, the protective effects
of medications taken by some participants, possible lack of adjustments for other confounders, and
inaccurate determinations of BP [42]. In this study we established negative confounding for the PM1
and PM2.5 outcomes (Tables 3 and 4). The statistical analysis indicated that McAuley’s ISI, with the
highest missing rate (n = 15, 23.81%), was the potential variable causing this phenomenon. McAuley’s
ISI is a measure of insulin sensitivity, and according to the study outcomes, the index was mainly
affected by fine particulate matter concentrations. We propose that high concentrations of PM1 and
PM2.5 may result in low a McAuley’s ISI that, in turn, can lead to increased HR. Confirmation of this
proposed pathway can be a focus of future studies.
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An important and novel aspect of the current study, which suggests an adverse association
between exposure to indoor particulate matter and vascular risk factors, is that the data were derived
from a population living in high-income setting where air quality is usually very good by international
standards. Most previous studies of indoor air quality on health outcomes have been conducted in
lower and middle-income countries where exposure to high levels of indoor air particulate matter is
common due to poor indoor ventilation, heating and cooking practices. In this study, median levels of
PM2.5 and PM10 were within the Australian National Environmental Protection Measures (NEPM) 24-h
exposure standards of 25 µg/m3 and 50 µg/m3, respectively. Study participants, who lived in houses
less than 300 m from busy roads or that allowed smoking inside were exposed to PM concentrations
that exceeded the NEPM standards.
In the context of cardiovascular (CV) risk factors, BP is strongly and directly related to CV
mortality [43] and is ranked as the leading risk factor for the global diseases burden, having accounted
for more than nine million deaths in 2010 [44]. Furthermore, Lim [44] stated that while higher levels
of both PM and BP are each individually linked to premature morbidity and mortality, a biological
interconnection between these two leading risk factors could represent an unprecedented threat to
global public health.
Limitations
This pilot study on a small sample was conducted over a relatively short duration. Hence seasonal
variations in IAP/OAP (outdoor air pollution) are embedded in these results. Our significant findings
suggest a particularly large effect in comparison to data from other studies. In part, this could have
arisen from unmeasured indoor exposure data on ozone, ultrafine particles, and nitrogen dioxide. The
latter are known to independently influence CVD risk and correlate strongly with PM. Hence their
non-measurement would possibly have biased our study outcomes [45]. In addition, a single 24-h
measure may not represent the usual indoor air particle concentration, and this is considered a study
limitation. Another limitation acknowledged by the authors is that the chemical composition of the
specific PM constituents responsible for the observed adverse effects on HR and BP were not identified.
5. Conclusions
In this observational study we demonstrate significant positive associations between several
measures of indoor PM and both HR and BP, after accounting for number of covariates including
age, gender, smoking, BMI, high BP, and taking prescription medication. Overall, the data provide
additional support to the thesis that indoor air pollution is an important modifiable factor in the risk
of hypertension. Future studies should be conducted over an extended period of time and include
other important indoor air pollutants such as volatile organic compounds and formaldehyde.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/15/9/2026/
s1, Figure S1: Percentage changes (95% CI) in outcome variables associated with one interquartile range (IQR)
increase in PM concentration exposures ¥—for all subjects (n = 63), Figure S2: Percentage changes (95% CI) in
outcome variables associated with one interquartile range (IQR) increase in PM concentration exposures ¥—for
subjects who answered “no” to “high blood pressure” (n = 41).
Author Contributions: K.R. and M.S. contributed to the study design and execution, data interpretation and
writing the manuscript. Y.Z. conducted the statistical analysis and contributed to the data interpretation and
writing the manuscript. C.R. and R.H. participated in the study execution, data interpretation and writing
the manuscript.
Funding: This research received no external funding.
Acknowledgments: We acknowledge the time and effort of all participants in this study.
Conflicts of Interest: The authors declare no conflict of interest.
Int. J. Environ. Res. Public Health 2018, 15, 2026 8 of 10
References
1. Bromfield, S.; Muntner, P. High Blood Pressure: The Leading Global Burden of Disease Risk Factor and the
Need for Worldwide Prevention Programs. Curr. Hypertens. Rep. 2013, 15, 134–136. [CrossRef] [PubMed]
2. Forouzanfar, M.H.; Afshin, A.; Alexander, L.T.; Anderson, H.R.; Bhutta, Z.A.; Biryukov, S.; Brauer, M.;
Burnett, R.; Cercy, K.; Charlson, F.J.; et al. Global, regional, and national comparative risk assessment
of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015:
A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1659–1724. [CrossRef]
3. World Health Organisation (WHO). World Health Statistics 2014. Available online: http://www.who.int/
gho/publications/world_health_statistics/2014/en/ (accessed on 26 July 2018).
4. Wallace, L. Indoor sources of ultrafine and accumulation mode particles: Size distributions, size-resolved
concentrations and source strengths. Aerosol Sci. Technol. 2006, 40, 348–360. [CrossRef]
5. Waring, M.S.; Siegel, J.A. An evaluation of the indoor air quality in bars before and after a smoking ban in
Austin, Texas. J. Expo. Sci. Environ. Epidemiol. 2007, 17, 260–268. [CrossRef] [PubMed]
6. Schripp, T.; Markewitz, D.; Uhde, E.; Salthammer, T. Does e-cigarette consumption cause passive vaping?
Indoor Air 2013, 23, 25–31. [CrossRef] [PubMed]
7. Waring, M. Secondary organic aerosol in residences: Predicting its fraction of fine particle mass and
determinants of formation strength. Indoor Air 2014, 24, 376–389. [CrossRef] [PubMed]
8. Morawska, L.; Ayokoa, G.A.; Baec, G.N.; Buonannoa, G.; Chaoe, C.Y.H.; Clifforda, C.; Fue, S.C.; Hännineng, O.;
Hea, C.; Isaxon, C.; et al. Airborne particles in indoor environment of homes, schools, offices and aged care
facilities: The main routes of exposure. Environ. Int. 2017, 108, 75–83. [CrossRef] [PubMed]
9. Brook, R.D.; Rajagopalan, S. Particulate matter air pollution and atherosclerosis. Curr. Atheroscler. Rep.
2010, 12, 291–300. [CrossRef] [PubMed]
10. Brook, R.D.; Rajagopalan, S.; Pope, C.A., 3rd; Brook, J.R.; Bhatnagar, A.; Diez-Roux, A.V.; Holguin, F.;
Hong, Y.; Luepker, R.V.; Mittleman, M.A.; et al. Particulate matter air pollution and cardiovascular disease:
An update to the scientific statement from the American Heart Association. Circulation 2010, 121, 2331–2378.
[CrossRef] [PubMed]
11. Dockery, D.W.; Stone, P.H. Cardiovascular risks from fine particulate air pollution. N. Engl. J. Med. 2007, 356,
511–513. [CrossRef] [PubMed]
12. Zeka, A.; Sullivan, J.R.; Vokonas, P.S.; Sparrow, D.; Schwartz, J. Inflammatory markers and particulate air
pollution: Characterizing the pathway to disease. Int. J. Epidemiol. 2006, 35, 1347–1354. [CrossRef] [PubMed]
13. Langrish, J.P.; Bosson, J.; Unosson, J.; Muala, A.; Newby, D.E.; Mills, N.L.; Blomberg, A.; Sandström, T.
Cardiovascular effects of particulate air pollution exposure: Time course and underlying mechanisms.
J. Intern. Med. 2012, 272, 224–239. [CrossRef] [PubMed]
14. Nelin, T.D.; Joseph, A.M.; Gorr, M.W.; Wpld, L.E. Direct and indirect effects of PM on the cardiovascular
system. Toxicol. Lett. 2012, 208, 293–299. [CrossRef] [PubMed]
15. Brasche, S.; Bischof, W. Daily time spent indoors in German homes–baseline data for the assessment of
indoor exposure of German occupants. Int. J. Hyg. Environ. Health 2005, 208, 247–253. [CrossRef] [PubMed]
16. Leech, J.A.; Nelson, W.C.; Burnett, R.T.; Aaron, S.; Raizenne, M.E. It’s about time: A comparison of Canadian
and American time–activity patterns. J. Expo. Anal. Environ. Epidemiol. 2002, 12, 427–432. [CrossRef]
[PubMed]
17. Morawska, L.; Afshari, A.; Bae, G.N.; Buonanno, G.; Chao, C.Y.; Hänninen, O.; Hofmann, W.; Isaxon, C.;
Jayaratne, E.R.; Pasanen, P.; et al. Indoor aerosols: From personal exposure to risk assessment. Indoor Air
2013, 23, 462–487. [CrossRef] [PubMed]
18. The World Bank. World Bank Country and Lending Groups. 2018. Available online: https://datahelpdesk.
worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed on
26 July 2018).
19. Baumgartner, J.; Schauer, J.J.; Ezzati, M.; Lu, L.; Cheng, C.; Patz, J.A.; Bautista, L.E. Indoor air pollution
and blood pressure in adult women living in rural China. Environ. Health Perspect. 2011, 119, 1390–1395.
[CrossRef] [PubMed]
20. Butler, D.A.; Madhavan, G. Communicating the health effects of indoor exposure to particulate matter.
Indoor Air 2017, 27, 503–505. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2018, 15, 2026 9 of 10
21. American Thoracic Society (ATS). Recommended respiratory disease questionnaires for use with adults and
children in epidemiological research. Epidemiology Standardised Project ATS, DLD-78. Am. Rev. Respir. Dis.
1978, 118, 10–23.
22. Rumchev, K.B.; Spickett, J.T.; Bulsara, M.K.; Phillips, M.R.; Stick, S.M. Domestic exposure formaldehyde
Significantly increases the risk of asthma in young children. Eur. Respir. J. 2002, 20, 403–408. [CrossRef]
[PubMed]
23. Rumchev, K.B.; Spickett, J.T.; Bulsara, M.K.; Phillips, M.R.; Stick, S.M. Association of domestic exposure to
volatile organic compounds with asthma in young children. Thorax 2004, 59, 746–751. [CrossRef] [PubMed]
24. Rumchev, K.; Win, T.; Bertolatti, D.; Satvinder, D. Prevalence of respiratory symptoms among women
and children in rural Myanmar-disease burden assessment attributable to household biomass smoke.
Indoor Built Environ. 2015, 25, 728–736. [CrossRef]
25. Ping-Delfos, W.; Soares, M. Diet induced thermogenesis, fat oxidation and food intake following sequential
meals: Influence of calcium and vitamin D. Clin. Nutr. 2011, 30, 376–383. [CrossRef] [PubMed]
26. Soares, M.J.; Kuriyan, R.; Kurpad, A.V. Calcium and vitamin D modulate postprandial vascular function:
A pilot dose-response study. Diabetes Metab. Syndr. Clin. Res. Rev. 2010, 4, 128–131. [CrossRef]
27. Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L., Jr.; Jones, D.W.;
Materson, B.J.; Oparil, S.; Wright, J.T., Jr.; et al. The seventh report of the Joint National Committee on
prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. JAMA 2003, 289,
2560–2572. [CrossRef] [PubMed]
28. Atkinson, R.W.; Carey, I.M.; Kent, A.J.; van Staa, T.P.; Anderson, H.R.; Cook, D.G. Long-term exposure to
outdoor air pollution and incidence of cardiovascular diseases. Epidemiology 2013, 24, 44–53. [CrossRef]
[PubMed]
29. Ying, Z.; Xu, X.; Bai, Y.; Zhong, J.; Chen, M.; Liang, Y.; Zhao, J.; Liu, D.; Morishita, M.; Sun, Q.; et al. Long-term
exposure to concentrated ambient PM2.5 increases mouse blood pressure through abnormal activation of
the sympathetic nervous system: A role for hypothalamic inflammation. Environ. Health Perspect. 2014, 122,
79–86. [CrossRef] [PubMed]
30. Zhao, X.; Sun, Z.; Ruan, Y.; Yan, J.; Mukherjee, B.; Yang, F.; Duan, F.; Sun, L.; Liang, R.; Lian, H.; et al. Personal
black carbon exposure influences ambulatory blood pressure: Air pollution and cardiometabolic disease
(AIRCMD-China) study. Hypertension 2014, 63, 871–877. [CrossRef] [PubMed]
31. Palatini, P.; Graniero, G.R.; Mormino, P.; Nicolosi, L.; Mos, L.; Visentin, P.; Pessina, A.C. Relation between
physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST
Trial. Hypertension and Ambulatory Recording Venetia Study. Circulation 1994, 90, 2870–2876. [CrossRef]
[PubMed]
32. Fox, K.; Ford, I.; Steg, P.G.; Tendera, M.; Robertson, M.; Ferrari, R. Relationship between ivabradine treatment
and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic
dysfunction with limiting angina: A subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Eur. Heart J. 2009, 30, 2337–2345. [CrossRef] [PubMed]
33. Dianat, M.; Radmanesh, E.; Badavi, M.; Goudarzi, G.; Mard, S.A. The effects of PM10 on electrocardiogram
parameters, blood pressure and oxidative stress in healthy rats: The protective effects of vanillic acid.
Environ. Sci. Pollut. Res. Int. 2016, 23, 19551–19560. [CrossRef] [PubMed]
34. Zhang, H.; Qian, J.; Zhao, H.; Wang, J.; Zhu, H.; Zhou, Y.; Wang, J.; Guo, J.; Gehendra, M.; Qiu, H.; et al.
A study of the association between atmospheric particulate matter and blood pressure in the population.
Blood Press 2016, 25, 169–176. [CrossRef] [PubMed]
35. Dvonch, J.T.; Kannan, S.; Schulz, A.J.; Keeler, G.J.; Mentz, G.; House, J.; Benjamin, A.; Max, P.; Bard, R.L.;
Brook, R.D. Acute effects of ambient particulate matter on blood pressure: Differential effects across urban
communities. Hypertension 2009, 53, 853–859. [CrossRef] [PubMed]
36. McGrath, B.P. Ambulatory blood pressure monitoring. Med. J. Aust. 2002, 176, 588–592. [PubMed]
37. Ohkubo, T.; Kikuya, M.; Asayama, K.; Metoki, H.; Hara, A.; Inoue, R.; Obara, T.; Hirose, T.; Hatanaka, R.;
Hozawa, A.; et al. Incorporating self-blood pressure measurements at home in the guideline from the
Ohasama study. Blood Press Monit. 2007, 12, 407–409. [CrossRef] [PubMed]
38. Brook, R.D.; Weder, A.B.; Rajagopalan, S. “Environmental hypertensionology” the effects of environmental
factors on blood pressure in clinical practice and research. J. Clin. Hypertens. 2011, 13, 836–842. [CrossRef]
[PubMed]
Int. J. Environ. Res. Public Health 2018, 15, 2026 10 of 10
39. Lin, Z.; Niu, Y.; Chen, R.; Xu, W.; Li, H.; Liu, C. Fine particulate matter constituents and blood pressure
in patients with chronic obstructive pulmonary disease: A panel study in Shanghai, China. Environ. Res.
2017, 18, 291–296. [CrossRef] [PubMed]
40. Ibald-Mulli, A.; Timonen, K.L.; Peters, A.; Heinrich, J.; Wölke, G.; Lanki, T.; Buzorius, G.; Kreyling, W.G.; de
Hartog, J.; Hoek, G.; et al. Effects of particulate air pollution on blood pressure and heart rate in subjects
with cardiovascular disease: A multicenter approach. Environ. Health Perspect. 2004, 112, 369–377. [CrossRef]
[PubMed]
41. Madsen, C.; Nafstad, P. Associations between environmental exposure and blood pressure among
participants in the Oslo Health Study (HUBRO). Eur. J. Epidemiol. 2006, 21, 485–491. [CrossRef] [PubMed]
42. Brook, R.D. You are what you breathe: Evidence linking air pollution and blood pressure. Curr. Hypertens. Rep.
2005, 7, 427–434. [CrossRef] [PubMed]
43. Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R. Age-specific relevance of usual blood pressure
to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies.
Lancet 2002, 360, 1903–1913. [PubMed]
44. Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; Amann, M.; Anderson, H.R.;
Andrews, K.G.; Aryee, M.; et al. A comparative risk assessment of burden of disease and injury attributable
to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet 2012, 380, 2224–2260. [CrossRef]
45. Zeger, S.L.; Thomas, D.; Dominici, F.; Samet, J.M.; Schwartz, J.; Dockery, D.; Cohen, A. Exposure measurement
error in time-series studies of air pollution: Concepts and consequences. Environ. Health Perspect. 2000, 108,
419–426. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
